Pharmaceutical Preparations
Standard Industrial Classification: SIC 2834
Industry Insider Sentiment Analysis
The Pharmaceutical Preparations sector (SIC 2834) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-15 21:02 | 2025-04-10 | RMTI | ROCKWELL MEDICAL, INC. | Irrevocable Larson Family Investment Trust | 10% owner | BUY | $1.07 | 87,500 | $94,019 | 3,557,500 |
| 2025-04-14 13:30 | 2025-04-11 | RNXT | RenovoRx, Inc. | Agah Ramtin | Director, Officer | BUY | $0.80 | 20,000 | $16,000 | 1,098,460 |
| 2025-04-15 01:23 | 2025-04-11 | TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | Officer | SELL | $13.14 | 48 | $631 | 89,990 |
| 2025-04-14 23:13 | 2025-04-10 | XNCR | Xencor Inc | Cornelissen Bart Jan | Officer | SELL | $8.06 | 3,750 | $30,233 | 61,348 |
| 2025-04-15 01:57 | 2025-04-10 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | Director, Officer | BUY | $5.08 | 20,000 | $101,600 | 792,680 |
| 2025-04-15 00:58 | 2025-04-10 | CORT | CORCEPT THERAPEUTICS INC | Swisher Daniel N JR | Director | OPT+S | $70.22 | 2,200 | $154,484 | 0 |
| 2025-04-14 23:17 | 2025-04-14 | ANIP | Ani Pharmaceuticals Inc. | Cook Meredith | Officer | SELL | $68.96 | 400 | $27,584 | 80,145 |
| 2025-04-12 04:45 | 2025-04-09 | OSTX | OS Therapies Inc | Auerbach Shalom | 10% owner | SELL | $1.36 | 60,012 | $81,568 | 2,746,199 |
| 2025-04-12 01:00 | 2025-04-10 | AKRO | Akero Therapeutics, Inc. | Cheng Andrew | Director, Officer | SELL | $35.23 | 30,000 | $1,056,780 | 624,324 |
| 2025-04-12 04:57 | 2025-04-09 | KROS | Keros Therapeutics, Inc. | ADAR1 Capital Management, LLC | 10% owner | BUY | $10.13 | 934,258 | $9,464,501 | 4,392,737 |
| 2025-04-12 01:20 | 2025-04-09 | ARWR | Arrowhead Pharmaceuticals Inc. | Anzalone Christopher Richard | Director, Officer | SELL | $10.87 | 141,122 | $1,533,333 | 3,921,255 |
| 2025-04-12 00:22 | 2025-04-09 | KALV | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners III, L.P. | 10% owner | BUY | $9.42 | 25,000 | $235,500 | 5,303,985 |
| 2025-04-11 20:23 | 2025-04-10 | GOVX | GeoVax Labs, Inc. | SPENCER JOHN N JR | Director | BUY | $0.98 | 10,000 | $9,800 | 11,402 |
| 2025-04-12 00:29 | 2025-04-09 | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Director, 10% owner | BUY | $10.21 | 149,075 | $1,522,518 | 656,513 |
| 2025-04-10 23:29 | 2025-04-09 | TXMD | TherapeuticsMD, Inc. | Walker Marlan D | Officer | BUY | $0.87 | 2,303 | $1,994 | 73,149 |
| 2025-04-11 01:00 | 2025-04-07 | AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Officer | OPT+S | $35.88 | 6,250 | $224,261 | 169,721 |
| 2025-04-11 00:17 | 2025-04-08 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | Officer | OPT+S | $60.14 | 20,760 | $1,248,490 | 19,209 |
| 2025-04-11 00:16 | 2025-04-08 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | Officer | SELL | $60.99 | 17,750 | $1,082,498 | 22,620 |
| 2025-04-11 02:02 | 2025-04-08 | RNXT | RenovoRx, Inc. | Kocak Ron | Officer | BUY | $0.79 | 12,595 | $10,011 | 12,595 |
| 2025-04-10 23:30 | 2025-04-09 | RNXT | RenovoRx, Inc. | Agah Ramtin | Director, Officer | BUY | $0.81 | 30,000 | $24,399 | 1,078,460 |
| 2025-04-10 13:02 | 2025-04-09 | RNXT | RenovoRx, Inc. | Bagai Shaun | Director, Officer | BUY | $0.83 | 10,000 | $8,300 | 312,540 |
| 2025-04-10 15:39 | 2025-04-08 | MBX | MBX Biosciences, Inc. | Pescovitz Ora H. | Director | BUY | $5.89 | 7,693 | $45,312 | 24,329 |
| 2025-04-10 23:01 | 2025-04-10 | GOVX | GeoVax Labs, Inc. | Sharkey John W. | Officer | BUY | $0.99 | 6,000 | $5,940 | 6,191 |
| 2025-04-10 23:02 | 2025-04-10 | AGIO | Agios Pharmaceuticals Inc. | FOUSE JACQUALYN A | Director | OPT+S | $25.90 | 7,497 | $194,172 | 149,220 |
| 2025-04-11 00:07 | 2025-04-10 | OPK | OPKO HEALTH, INC. | FROST PHILLIP MD ET AL | Director, Officer, 10% owner | BUY | $1.36 | 125,000 | $169,713 | 214,001,448 |
| 2025-04-10 23:07 | 2025-04-09 | RCKT | ROCKET PHARMACEUTICALS, INC. | Patel Kinnari | Officer | BUY | $4.70 | 21,099 | $99,165 | 26,774 |
| 2025-04-11 02:06 | 2025-04-09 | PVLA | PALVELLA THERAPEUTICS, INC. | JENKINS GEORGE M | Director | BUY | $20.20 | 4,990 | $100,798 | 13,516 |
| 2025-04-10 23:15 | 2025-04-08 | ACUT | Accustem Sciences Inc. | CERRONE GABRIELE M | Director, 10% owner | BUY | $0.67 | 38,000 | $25,285 | 4,910,759 |
| 2025-04-11 00:40 | 2025-04-10 | CYTK | CYTOKINETICS INC | Blum Robert I | Director, Officer | SELL | $36.77 | 5,000 | $183,850 | 422,629 |
| 2025-04-09 23:44 | 2025-04-07 | XOMA | XOMA Royalty Corp | Sitko Bradley | Officer | BUY | $24.70 | 2,000 | $49,400 | 5,045 |
| 2025-04-09 14:40 | 2025-04-08 | PEPG | PepGen Inc. | McArthur James G | Director, Officer | BUY | $1.15 | 41,500 | $47,725 | 103,913 |
| 2025-04-09 23:25 | 2025-04-07 | ELVN | Enliven Therapeutics, Inc. | Patel Anish | Officer | SELL | $18.04 | 6,667 | $120,269 | 316,643 |
| 2025-04-10 04:30 | 2025-04-08 | RNXT | RenovoRx, Inc. | Marton Laurence | Director | BUY | $0.85 | 12,050 | $10,218 | 45,684 |
| 2025-04-09 19:45 | 2025-04-08 | RNXT | RenovoRx, Inc. | Agah Ramtin | Director, Officer | BUY | $0.84 | 26,000 | $21,840 | 1,048,460 |
| 2025-04-09 04:36 | 2025-03-26 | NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | GARNETT KEITHLY | Director, Officer | SELL | $24.85 | 6,616 | $164,425 | 44,053 |
| 2025-04-09 04:36 | 2025-03-26 | NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | WALTERS PATRICK | Officer | SELL | $24.85 | 11,847 | $294,431 | 78,885 |
| 2025-04-09 04:35 | 2025-03-26 | NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | CHIANG MING-FU (ALAN) | Director | SELL | $24.85 | 57,696 | $1,433,913 | 384,180 |
| 2025-04-09 04:35 | 2025-03-26 | NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | CHEN THOMAS C | Director, Officer, 10% owner | SELL | $24.85 | 39,233 | $975,054 | 261,242 |
| 2025-04-08 13:05 | 2025-04-07 | GLSI | Greenwich LifeSciences, Inc. | Patel Snehal | Director, Officer, 10% owner | BUY | $9.10 | 3,600 | $32,760 | 5,561,602 |
| 2025-04-09 04:52 | 2025-04-04 | VREO | Vireo Growth Inc. | Chicago Atlantic Credit Opportunities, LLC | 10% owner | BUY | $0.42 | 60,000 | $25,158 | 11,206,278 |
| 2025-04-09 00:30 | 2025-04-04 | OKUR | OnKure Therapeutics, Inc. | Leverone Jason A. | Officer | SELL | $2.94 | 3,122 | $9,178 | 13,209 |
| 2025-04-09 00:32 | 2025-04-04 | OKUR | OnKure Therapeutics, Inc. | Saccomano Nicholas A | Director, Officer | SELL | $2.94 | 874 | $2,570 | 3,682 |
| 2025-04-08 18:30 | 2025-04-07 | RNXT | RenovoRx, Inc. | Bagai Shaun | Director, Officer | BUY | $0.83 | 10,000 | $8,300 | 302,540 |
| 2025-04-08 23:45 | 2025-04-07 | SPRY | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | OPT+S | $12.30 | 50,002 | $615,075 | 210,346 |
| 2025-04-09 04:36 | 2025-03-26 | NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | Heshmatpour Amir F | Director | SELL | $24.85 | 38,464 | $955,942 | 256,120 |
| 2025-04-09 00:34 | 2025-04-08 | OPK | OPKO HEALTH, INC. | FROST PHILLIP MD ET AL | Director, Officer, 10% owner | BUY | $1.48 | 125,000 | $184,650 | 213,876,448 |
| 2025-04-09 00:01 | 2025-04-07 | PHAT | Phathom Pharmaceuticals, Inc. | Henderson Molly | Officer | SELL | $4.55 | 3,678 | $16,740 | 89,868 |
| 2025-04-09 02:24 | 2025-04-04 | ARDX | Ardelyx Inc. | RAAB MICHAEL | Director, Officer | OPT+S | $4.59 | 41,666 | $191,151 | 1,615,587 |
| 2025-04-09 04:30 | 2025-04-04 | NUVB | Nuvation Bio Inc. | Hung David | Director, Officer, 10% owner | BUY | $1.64 | 500,000 | $820,200 | 58,781,054 |
| 2025-04-08 23:06 | 2025-04-04 | RCKT | ROCKET PHARMACEUTICALS, INC. | Ondrey Aaron | Officer | SELL | $5.29 | 7,489 | $39,647 | 129,650 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Pharmaceutical Preparations sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2834) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Pharmaceutical Preparations
Every transaction in the Pharmaceutical Preparations industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.